News

The new patent entitled, ‘Deep Draw Container Forming Method,’ covers manufacturing technology of VersiDoser and VRx2 drug and biologic delivery systems. Mystic claims its delivery platforms offer preservative

The trial evaluated patients who were divided into three arms: placebo, low dose and high dose EPI-A0001. In the trial, EPI-A0001 improved neurological function as assessed by the

The launch follows the approval from the US Food and Drug Administration for Letrozole 2.5mg Tablets’ abbreviated new drug application (ANDA). Letrozole tablets are bioequivalent to Novartis’ Femara,

Hong Yu has succeeded Taylor Guo, who has left the company for personal reasons. Yu said he would like to thank Taylor Guo for his commitment and dedication

Three controlled clinical trails comprising 1,239 adult patients have established the efficacy of ezogabine as adjunctive therapy in partial onset seizures. The companies plan to introduce the product

Adcetris is an antibody-drug conjugate (ADC) constituting an anti-CD30 monoclonal antibody attached by a protease-cleavable linker to a synthetic drug, monomethyl auristatin E (MMAE) using Seattle Genetics’ proprietary

With this amendment the rights and obligations under the R&D and licensing agreement will be transferred from NTS Plus to the newly established Russian biotech company International Biotech

Rapidscan Pharma claims Rapiscan is a non-weight based, infusion pump-free pharmacological stress agent available in the UK. Unlike older agents, Rapiscan requires no dose adjustment for varying body

Biota Scientific Management is a wholly subsidiary of an Australia-based anti-infective drug developer, Biota. As part of this 5-year grant funding, the company expects to receive $830,287 in